US adopts ICH DSUR format for annual clinical trial safety reports
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has adopted a guideline by the International Conference on Harmonisation that describes the format, content and timing of a development safety update report (DSUR) for an investigational drug1,2.